Bio€quity Europe 2026: GenSearch in Prague

Bio€quity Europe 2026: Sébastien Stoitzner Will Be There for GenSearch

Bio€quity Europe 2026, taking place in Prague from 4 to 6 May 2026, is a key event for European growth-stage biotechnology companies seeking funding, strategic partnerships and international visibility..
Read more “Bio€quity Europe 2026: GenSearch in Prague”

GenSearch Attending the 2026 HealthTech Trophies

Stephanie, Pauline and Sébastien will attend the 2026 HealthTech Trophies on 30 March 2026, joining one of the leading events celebrating HealthTech innovation, young HealthTech companies, and the future of healthcare innovation in France. 

Read more “GenSearch Attending the 2026 HealthTech Trophies”

Swiss Biotech Day 2026: Connecting Global Biotech in Basel

Swiss Biotech Day 2026: Meet Us in Basel

Swiss Biotech Day 2026 will take place in Basel on 4–5 May 2026.
We are pleased to confirm that GenSearch will be attending and look forward to meeting partners and peers from across the life sciences community.

  • Location: Congress Center Basel, Switzerland
  • Welcome reception: 3 May 2026
  • Heiko Bruhn will attend on behalf of GenSearch

The event brings together thousands of biotech professionals from around the world and offers
presentations, panel discussions, and one-to-one partnering opportunities.

If you are attending we would be happy to connect in Basel.

Swiss Biotech Day 2026

𝗙𝗿𝗼𝗺 𝗽𝗿𝗲𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗽𝗲𝗼𝗽𝗹𝗲 – 𝗿𝗲𝗳𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗳𝗿𝗼𝗺 𝗕𝗮𝘀𝗲𝗹

At GenSearch, we were proud to co-host the recent HealthTech Dinner in Basel alongside PwC Switzerland. This invitation-only event brought together senior leaders from across the pharma, biotech, and life sciences sectors. The aim was to explore how the industry is transitioning from product-led models to patient- and consumer-centric ecosystems.
Read more “𝗙𝗿𝗼𝗺 𝗽𝗿𝗲𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗽𝗲𝗼𝗽𝗹𝗲 – 𝗿𝗲𝗳𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗳𝗿𝗼𝗺 𝗕𝗮𝘀𝗲𝗹”

Is ESG Already Central to Healthtech Strategy?

Is ESG Already Central to Healthtech Strategy?
Our GenSearch’s roundtable, “ESG, déjà au cœur de la stratégie des Healthtech?”, perfectly aligned with our commitment to share market topics expertise within our network and to promoting sustainable practices across the life sciences, biotech, and Healthtech sectors..

Read more “Is ESG Already Central to Healthtech Strategy?”

Bio-Equity 2025

We are pleased to announce that Sebastien Stoitzner will be attending BioEquity in Bruges 12-14 May. As a key figure in our organisation’s commitment to growth and innovation within the Life Sciences sector, Sebastien’s presence at this renowned conference underlines our dedication to staying at the forefront of industry developments.
Read more “Bio-Equity 2025”

Exploring the Future of Cell and Gene Therapies at Our HealthTech Leadership Dinner in Basel

We had the pleasure of co-hosting our #HealthTech Dinner in Basel with our partners at PwC Switzerland—an evening dedicated to exploring the evolving future of cell and gene therapies.

A heartfelt thank you to our guest speakers, Joshi Venugopal (Novartis Gene Therapies & Rare Diseases) and Gunther Busam (Orchard Therapeutics – U.S.), for their thought-provoking contributions.

Read more “Exploring the Future of Cell and Gene Therapies at Our HealthTech Leadership Dinner in Basel”